Galvani Bioelectronics

GSK and Verily’s Galvani Bioelectronics forges ahead, ushering in a new era of medicine

Monday, August 8, 2016

Galvani Bioelectronics, a newly established company launched by GlaxoSmithKline (GSK) and Verily Life Sciences (formerly Google Life Sciences), will explore a new wave of science. Galvani Bioelectronics will focus on the development of bioelectronic medicine: the use of implantable devices to modify the electrical signals that nerve cells use to communicate within the body.

[Read More]